Glycine Antagonist in Neuroprotection for Patients with Acute Stroke "GAIN International"

Completed

Phase 3 Results

Summary of Purpose

To test whether gavestinel can improve functional outcome after acute stroke in human beings.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 12 August 2008.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Sponsors

  • Glaxo Wellcome, Research Triangle, NC

Trial Design

One of two randomized, international, double-blind, placebo controlled trials. GAIN International had 1804 participants. Two substudies are planned: (1) lesion volume measured by MRI-DWI, (2) health-related quality of life.

Contacts

  • Gain International Study Group, Glaxo Wellcome

    kr.lees@clinmed.gla.ac.uk